| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | Fromkin Andrew J. Director | Sale | -221,951 | -74.90%74,382 | $33.51 | $7,438,111 | View SEC filing | |
| 2026-05-22 | Gloria Melanie Chief Operating Officer | Sale | -3,115 | -1.27%242,107 | $32.45 | $101,072 | View SEC filing | |
| 2026-05-20 | Pande Atul Director | Sale | -6,000 | -4.89%116,731 | $32.00 | $192,000 | View SEC filing | |
| 2026-05-01 | Susman Robert Graham Director | Sale | -2,502 | -6.43%36,394 | $27.17 | $67,979 | View SEC filing | |
| 2026-04-24 | Girao Tiago Chief Financial Officer | Sale | -25,760 | -9.42%247,596 | $29.62 | $763,011 | View SEC filing | |
| 2026-04-24 | Stout Jay S Chief Technology Officer | Sale | -2,754 | -1.08%251,685 | $29.62 | $81,573 | View SEC filing | |
| 2026-04-10 | Gloria Melanie Chief Operating Officer | Sale | -8,722 | -3.43%245,222 | $24.83 | $216,567 | View SEC filing | |
| 2026-04-10 | Van Tuyl Christopher Chief Legal Officer | Sale | -5,165 | -2.74%183,231 | $24.83 | $128,247 | View SEC filing | |
| 2026-04-10 | Stout Jay S Chief Technology Officer | Sale | -10,132 | -3.83%254,439 | $24.83 | $251,578 | View SEC filing | |
| 2026-04-03 | Venker Eric Chief Executive Officer | Sale | -14,229 | -42.11%19,561 | $24.10 | $342,854 | View SEC filing | |
| 2026-03-20 | Van Tuyl Christopher Chief Legal Officer | Sale | -2,877 | -1.92%147,053 | $24.97 | $71,839 | View SEC filing | |
| 2026-02-27 | Gloria Melanie Chief Operating Officer | Sale | -3,238 | -1.87%170,273 | $27.85 | $90,184 | View SEC filing | |
| 2026-01-23 | Stout Jay S Chief Technology Officer | Sale | -1,977 | -0.99%197,634 | $26.03 | $51,461 | View SEC filing | |
| 2026-01-09 | Stout Jay S Chief Technology Officer | Sale | -1,203 | -0.60%199,611 | $26.53 | $31,914 | View SEC filing | |
| 2025-12-19 | Van Tuyl Christopher Chief Legal Officer | Sale | -10,813 | -6.73%149,930 | $26.91 | $290,943 | View SEC filing | |
| 2025-12-12 | Roivant Sciences Ltd. Director, 10% Owner | Purchase | +16,666,666 | +17.24%113,317,007 | $21.00 | $349,999,986 | View SEC filing | |
| 2025-12-03 | Fromkin Andrew J. Director | Sale | -22,249 | -20.58%85,852 | $23.25 | $517,189 | View SEC filing | |
| 2025-12-03 | Hughes Douglas J. Director | Sale | -15,000 | -11.05%120,773 | $23.24 | $348,665 | View SEC filing | |
| 2025-11-21 | Gloria Melanie Chief Operating Officer | Sale | -12,626 | -6.78%173,511 | $23.62 | $298,237 | View SEC filing | |
| 2025-10-24 | Geffner Michael Chief Medical Officer | Sale | -2,595 | -1.18%217,958 | $19.03 | $49,383 | View SEC filing | |
| 2025-10-24 | Stout Jay S Chief Technology Officer | Sale | -2,520 | -1.24%200,814 | $19.03 | $47,956 | View SEC filing | |
| 2025-10-10 | Geffner Michael Chief Medical Officer | Sale | -1,272 | -0.57%220,553 | $16.30 | $20,734 | View SEC filing | |
| 2025-10-10 | Stout Jay S Chief Technology Officer | Sale | -1,585 | -0.77%203,334 | $16.30 | $25,836 | View SEC filing | |
| 2025-07-25 | Stout Jay S Chief Technology Officer | Sale | -2,805 | -1.35%204,919 | $18.15 | $50,911 | View SEC filing | |
| 2025-07-25 | Geffner Michael Chief Medical Officer | Sale | -2,385 | -1.06%221,825 | $18.15 | $43,288 | View SEC filing |
1-25 of 189
